Albion invests in RegGenome
We are pleased to announce our investment in Regulatory Genome Development Ltd (RegGenome), a commercial spin-out from the University of Cambridge.
MyMeds&Me announces exit to a private equity company
MyMeds&Me; a digital pharma company, has been acquired by Drug Safety and Pharmacovigilance Services Solutions (DSS)
AlbionVC leads a £13m Series A extension in TransFICC
Albion announces that is had led a £17 million Series A extension in TransFICC alongside existing institutional shareholders, which follows the original Series A for £7.8 million, announced in April 2020.TransFICC’s investors are AlbionV...